Cartalax
aka Ala-Glu-Asp
Healing & Recovery
Mechanism
Cartalax is a synthetic tripeptide (Ala-Glu-Asp / AED) from the Khavinson bioregulator series, studied in Russian preclinical models on fibroblast and chondrocyte cultures. Not FDA-approved; no Western clinical trials exist, and all published evidence originates from a single research group.
Identification
Vendors selling Cartalax
No vendor listings on file yet.
Research
No citations on file yet.